CDKN2B and hepatocellular carcinoma: Although the oncogenic roles of CDKN2B‐AS1 in HCC have been studied, there has been limited investigation into epidemiological aspects of HCC susceptibility and clinicopathologic characteristics conferred by genetic variants at CDKN2B‐AS1 loci.